Angiogenic footprints in diabetic retinopathy: opportunities for drug development-Reference-Cited by-同舟云学术

Angiogenic footprints in diabetic retinopathy: opportunities for drug development

Published:2022-07-25 Issue:1 Volume:39 Page:118-142
ISSN:0264-8725
Container-title:Biotechnology and Genetic Engineering Reviews
language:en
Short-container-title:Biotechnology and Genetic Engineering Reviews

Author:

Bhatia Shiveena¹,Babbar Ritchu¹,Zehravi Mehrukh²,Singh Balbir³,Chandel Parteek¹,Hasan Mohammad Mehedi⁴,Arora Rashmi¹,Gill Naresh S.⁵,Sindhu Rakesh K.¹,Ahmad Zubair⁶⁷,Khan Farhat S.⁸,Rahman Md. Habibur⁹^ORCID

Affiliation:

1. Chitkara College of Pharmacy, Chitkara University, Rajpura, India

2. Department of Clinical Pharmacy Girls Section, Prince Sattam Bin Abdul Aziz University Alkharj, Alkharj, Saudia Arabia

3. Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar, Punjab, India

4. Department of Biochemistry and Molecular Biology, Faculty of Life Science, Mawlana Bhashani Science and Technology University, Tangail, Bangladesh

5. Rayat Institute of Pharmacy, Ropar, India

6. Unit of Bee Research and Honey Production, Faculty of Science, King Khalid University, Abha, Saudi Arabia

7. Community College, Mahala Campus, King Khalid University (KKU), Abha, Kingdom of Saudi Arabia (KSA)

8. Biology Department, Faculty of Sciences and Arts, King Khalid University, Dhahran Al Janoub, Saudi Arabia

9. Department of Global Medical Science, Wonju College of Medicine, Yonsei University, Wonju, Korea

Publisher

Informa UK Limited

Subject

Molecular Biology,Bioengineering,Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/02648725.2022.2102880

Reference97 articles.

1. Anti-VEGF Therapy in Proliferative Diabetic Retinopathy

2. Curcumin Is an In Vivo Inhibitor of Angiogenesis

3. Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy

4. INTRAVITREAL BEVACIZUMAB FOR PROLIFERATIVE DIABETIC RETINOPATHY

5. REGRESSION OF RETINAL AND IRIS NEOVASCULARIZATION AFTER INTRAVITREAL BEVACIZUMAB (AVASTIN) TREATMENT

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological modulation of Sonic Hedgehog signaling pathways in Angiogenesis: A mechanistic perspective;Developmental Biology;2023-12

2. Panax Notoginseng Saponins Alleviate High Glucose-Induced Glomerular Endothelial Cell Injury by Inhibiting the ET-1/PKC/TGF-β1 Signaling Pathway;Journal of Biomedical Nanotechnology;2023-09-01

3. Therapeutic implication of Sonic Hedgehog as a potential modulator in ischemic injury;Pharmacological Reports;2023-06-22

4. Correlation of adiponectin, body mass index and waist-to-height ratio with the risk of developing gestational diabetes mellitus in hypertensive patients;TROP J PHARM RES;2023

5. Gancao Xiexin Decoction exerts anti-hyperglycemic and anti-hyperlipidemic effects in type 2 diabetes mellitus rats via IRS2/PI3K/Akt pathway;TROP J PHARM RES;2023